Authors: Zdravkovic, M Christiansen, T Eliot, L Agersoe, H Thomsen, MS Falch, JF Sogaard, B Ynddal, L Ilondo, MM

Citation: M. Zdravkovic et al., The pharmacokinetics, pharmacodynamics, safety and tolerability following 7 days daily oral treatment with NN703 in healthy male subjects, GROWTH H I, 11(1), 2001, pp. 41-48

Authors: Agerso, H Ynddal, L Sogaard, B Zdravkovic, M

Citation: H. Agerso et al., Pharmacokinetic and pharmacodynamic modeling of NN703, a growth hormone secretagogue, after a single po dose to human volunteers, J CLIN PHAR, 41(2), 2001, pp. 163-169

Authors: Zdravkovic, M Sogaard, B Ynddal, L Christiansen, T Agerso, H Thomsen, MS Falch, JE Ilondo, MM

Citation: M. Zdravkovic et al., The pharmacokinetics, pharmacodynamics, safety and tolerability of a single dose of NN703, a novel orally active growth hormone secretagogue in healthy male volunteers, GROWTH H I, 10(4), 2000, pp. 193-198

Authors: Gobburu, JVS Agerso, H Jusko, WJ Ynddal, L

Citation: Jvs. Gobburu et al., Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers, PHARM RES, 16(9), 1999, pp. 1412-1416